Resistance to Immunotherapeutic Antibodies in Cancer : Strategies to Overcome Resistance /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Edición: | 1st ed. 2013. |
| Colección: | Resistance to Targeted Anti-Cancer Therapeutics,
2 |
| Materias: |
Tabla de Contenidos:
- Preface
- Introduction and generation of chimeric and humanized mAbs
- mAbs targeted against cancer cells and antibodies targeted against the tumor microenvironment
- Antibodies directed against different major cancers: Effects when used alone or in combination with drugs
- Mechanisms of antibodies-mediated responses, in vitro and in vivo
- Molecular Pathways
- Molecular Signatures
- Identification of resistance targets for intervention
- Various chemicals that can sensitize resistant tumor cells
- Other mAbs
- Proteasome inhibitors
- Divalent mAbs
- Antibodies coupled to chemical inhibitors
- Antibodies coupled to cytokines
- Nanoparticles with mAbs
- Index.